Summary & Overview
HCPCS Level II M1219: Anaphylaxis Due to Vaccine on or Before Encounter Date
HCPCS Level II code M1219 identifies anaphylaxis occurring in temporal relation to vaccination, recorded on or before the date of the clinical encounter. Nationally, accurate capture of vaccine-associated anaphylaxis is important for patient safety surveillance, clinical care coordination, and appropriate claims adjudication given the urgent nature of the condition. Typical settings for services billed with this code include emergency departments and urgent care centers where acute allergic reactions are assessed and managed. Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical meaning, the service contexts where it is relevant, and the common modifiers used with this code. The brief also outlines what to expect for benchmarking and policy considerations relevant to national billing practice, and highlights areas where input data are not available. Data not available in the input include associated taxonomies, specific ICD-10 diagnosis mappings, and related procedure or service-line detail.
Billing Code Overview
HCPCS Level II code M1219 denotes anaphylaxis due to the vaccine on or before the date of the encounter. This code is used to report the clinical circumstance where a patient experiences anaphylactic reaction temporally associated with a vaccination.
-
Service type: Emergency evaluation and management or urgent care services related to acute allergic reaction
-
Typical site of service: Emergency department, urgent care center, or other acute care setting
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related procedure codes.
Clinical & Coding Specifications
Clinical Context
A 28-year-old patient presents to an urgent care clinic within 30 minutes of receiving a routine immunization with sudden onset of generalized hives, facial swelling, bronchospasm with wheeze and shortness of breath, hypotension (systolic blood pressure <90 mmHg), and altered mental status consistent with anaphylaxis due to the vaccine administered earlier that day. The clinical workflow begins with immediate triage and rapid assessment of airway, breathing and circulation, activation of emergency response protocols, administration of intramuscular epinephrine, supplemental oxygen, intravenous access, fluid resuscitation, and adjunctive therapies (antihistamines, corticosteroids, bronchodilators). The encounter is documented as anaphylaxis due to the vaccine on or before the date of the encounter and coded using the HCPCS Level II code M1219. The typical site of service is an urgent care center, emergency department, or outpatient clinic that administers vaccinations. Clinical documentation includes the vaccine given, time of administration, time of symptom onset, vital signs, treatments provided, response to treatment, informed consent for any procedures, and disposition (observation, transfer to higher level of care, or discharge with instructions and emergency kit).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when services required substantially greater effort or complexity than usual for management of severe anaphylaxis (must document rationale and report per payer rules). |